Esophageal squamous dysplasia and cancer: Is artificial intelligence our best weapon?


Journal

Best practice & research. Clinical gastroenterology
ISSN: 1532-1916
Titre abrégé: Best Pract Res Clin Gastroenterol
Pays: Netherlands
ID NLM: 101120605

Informations de publication

Date de publication:
Historique:
received: 21 12 2020
accepted: 22 12 2020
entrez: 26 6 2021
pubmed: 27 6 2021
medline: 21 7 2021
Statut: ppublish

Résumé

Esophageal cancer is the eight most common cancer in the world and is associated with a poor prognosis. Significant efforts are necessary to improve the detection of early squamous cell cancer such that curative endoscopic therapy can be offered. Studies have shown an overall miss rate of esophageal cancer of up to 6.4%. Human factors including fatigue and lack of attention may be a contributory factor. Computer aided detection and characterisation of early squamous cell cancer can be a second reader which potentially offsets these factors. Recent studies developing artificial intelligence systems show real promise in the detection of early squamous cell cancer and predicting depth of invasion to aid in the management of patients in the same endoscopic session. This has the potential to revolutionise this area of endoscopy.

Identifiants

pubmed: 34172257
pii: S1521-6918(20)30058-5
doi: 10.1016/j.bpg.2020.101723
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

101723

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Mohamed Hussein (M)

Division of Surgery and Interventional Sciences, University College London, London, UK; Department of Gastroenterology, University College London Hospital, London, UK. Electronic address: mohamed.hussein3@nhs.net.

Martin Everson (M)

Division of Surgery and Interventional Sciences, University College London, London, UK.

Rehan Haidry (R)

Department of Gastroenterology, University College London Hospital, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH